VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹162 Cr | ₹136 Cr | ₹79 Cr | ₹83 Cr | ₹93 Cr |
What is the latest Total Current Liabilities ratio of VENUS REMEDIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹162 Cr |
| Mar2025 | ₹136 Cr |
| Mar2024 | ₹79 Cr |
| Mar2023 | ₹83 Cr |
| Mar2022 | ₹93 Cr |
How is Total Current Liabilities of VENUS REMEDIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹162 Cr | 18.69 | |
| Mar2025 | ₹136 Cr | 71.61 | |
| Mar2024 | ₹79 Cr | -3.82 | |
| Mar2023 | ₹83 Cr | -10.97 | |
| Mar2022 | ₹93 Cr | - | |
Compare Total Current Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,187.2 Cr | -2.4% | -6% | 253.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -2.4% |
-6% |
253.1% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses